Researchers tested new CAR designs in NK-92 cells and found the modified cells killed tumor cells more effectively, showing stronger anti-cancer activity.
Researchers at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy (CTC) are exploring a key question in cancer immunotherapy: how to “wire” engineered natural killer (NK) cells so they respond faster and hit harder when they encounter a tumor.
Using the NK-92 cell line, the team tested new chimeric antigen receptor (CAR) designs that include specific costimulatory domains, such as 2B4 and DAP12. These domains act like internal activation circuits, shaping how strongly an NK cell ramps up its attack once the CAR recognizes a target.
In the experiments, adding 2B4 and DAP12 helped put the cells in a more aggressive state, making them “ready to attack” and improving their ability to destroy tumors. The results were published in Frontiers in Immunology.
The CTC is one of the Research, Innovation, and Dissemination Centers (RIDCs) funded by FAPESP. It operates within the Ribeirão Preto Blood Center and is affiliated with the general and teaching hospital (“Hospital das Clínicas”) of the Ribeirão Preto Medical School at the University of São Paulo (FMRP-USP).
Advancing CAR-NK Cell Design
CAR-based therapies have already changed outcomes for some cancers, especially hematological tumors, but most of what scientists know about the best internal signaling components comes from CAR-T cells. NK cells work differently, relying on a separate set of activation pathways, so translating CAR-T “recipes” to CAR-NK cells is not straightforward.
This study highlights how fine-tuning the costimulatory signals inside CAR-NK cells could make these therapies more potent and more consistent.
The researchers also explored a practical way to manage that power: temporary pharmacological control using dasatinib. Rather than permanently altering the cells, dasatinib was used as a short-term tool to modulate activation.
According to the Ribeirão Preto Blood Center Press Office, animal models showed that CAR-NK cells built with 2B4-DAP12 and pretreated with dasatinib achieved better tumor control than traditional versions. Together, the findings point toward CAR-NK treatments that are not only stronger, but also more controllable, which is a major goal for next-generation cell therapies.
DOI: 10.3389/fimmu.2025.1675877
Funding: São Paulo Research Foundation
News
Why More People in Their 30s Are Suddenly Getting Colon Cancer
A major Swiss study found that colorectal cancer is becoming increasingly common in adults under 50, even as rates decline in older age groups. Researchers in Switzerland have identified a concerning trend: while colorectal [...]
Researchers Compare MS Models to Human Tissue in Search for Better Therapies
Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve efforts to develop treatments that restore lost [...]
Scientists Discover Genetic “Off Switch” That Supercharges CAR T Cells Against Cancer
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single gene-regulating protein. CAR T-cell therapy is widely seen as a breakthrough in personalized cancer [...]
New Vitamin B12-Based Therapy Could Change How Brain Cancer Is Treated
Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and selectively accumulating in glioblastoma tissue. For decades, one of the biggest problems in brain cancer treatment has had [...]
Simple Fiber Supplement Cuts Knee Arthritis Pain in Just 6 Weeks, Study Finds
A daily inulin supplement may help reduce knee osteoarthritis pain while revealing a possible link between gut health, muscle function, and pain sensitivity. For millions of people living with knee osteoarthritis, managing chronic pain [...]
This Common Vitamin May Help Stop Prediabetes From Turning Into Diabetes
Vitamin D may help prevent type 2 diabetes in people with specific genetic variations, offering a possible path toward personalized diabetes prevention. More than 40% of U.S. adults have prediabetes, a condition in which [...]
Ebola, hantavirus: Is the world prepared for the next pandemic?
Funding cuts to health research and a growing antivaccine movement are making it harder than ever to respond to viruses. The World Health Organization (WHO) has declared that an Ebola outbreak in Uganda and [...]
May 2026 Healthcare News and Trends: Market Signals That Matter
Artificial intelligence is dominating headlines, telehealth has settled into a new normal, and digital health continues to promise transformation. However, much of what is being discussed in healthcare today reflects potential rather than reality. [...]
Scientists Rewire Donor Stem Cells To Outsmart Aggressive Blood Cancers
Researchers have tested a gene-edited stem cell transplant designed to shield healthy blood-forming cells from powerful cancer-targeting immunotherapies. For patients with highly aggressive blood cancers, stem cell transplantation can offer a rare chance at [...]
Recent Digital Health Trends, Insights and News – May 2026
Last month marked continued progress as digital health moves into its next phase — from AI expanding into drug discovery and core infrastructure to new federal pathways accelerating device access and home-based care. Together, [...]
Cancer Mystery Solved: Scientists Discover How Melanoma Becomes “Immortal”
Scientists have uncovered a previously overlooked mechanism that may help melanoma cells become effectively “immortal.” Cancer cells face a major problem before they can become deadly: They have to figure out how to stop [...]
How Visual Neurons Organize Thousands of Synaptic Inputs
Summary: A new study uncovered the organizational rules that determine how neurons in the primary visual cortex process information. By imaging both the cell bodies (soma) and the individual synapses (on dendritic spines) of [...]
Scientists Just Found a Surprising Way To Destroy “Forever Chemicals”
Scientists have uncovered a new mechanism that may help break down highly persistent PFAS pollutants. PFAS have earned the nickname “forever chemicals” for a reason. These industrial compounds are so chemically durable that they [...]
Scientists Discover Cheap Material That Kills Deadly Superbugs
A new sulfur-rich antimicrobial polymer shows strong effectiveness against fungal and bacterial pathogens and may offer an affordable solution to antimicrobial resistance. Antimicrobial resistance is creating growing challenges for both healthcare and food production, [...]
What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring
Like periodical cicadas, the insects for which it is nicknamed, SARS-CoV-2 Omicron subvariant BA.3.2 is only just beginning to emerge after lying low for an extended period since it first appeared. Although it was [...]
Scientists Say This Simple Supplement May Actually Reverse Heart Disease
Scientists in Japan say a common supplement may actually help “unclog” certain diseased heart arteries from the inside out. A simple food supplement sold in Japan may have helped reverse a dangerous form of [...]
